Botanical species · safety record

Balduina angustifolia

The EFSA Compendium of Botanicals holds 7 constituent measurements for Balduina angustifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Balduina angustifolia (Pursh) B.L.Rob.

7Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Angustibalin	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Helenalin	Live plants	Solvent extraction	—	Chromatographic tests	Resolve DOI
Helenalin	Live plants	Solvent extraction	0.024 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Neohelenalin	Live plants	Solvent extraction	—	Chromatographic tests	Resolve DOI
Rotenone	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Helenalin	Live plants	Solvent extraction	0.53 Percent	Traditional analytical techniques (wet chemical tests)	No resolvable identifier
Tenulin	Live plants	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

LEE, KH., ANUFORO, DC., HUANG, ES., PIANTADO.C. ANTITUMOR AGENTS .1. ANGUSTIBALIN, A NEW CYTOTOXIC SESQUITERPENE LACTONE FROM BALDUINA-ANGUSTIFOLIA (PURSH) ROBINS. JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, vol. 61, no. 4, p. 626-&. DOI
Herz, W., Mitra, R.B. Constituents of helenium species. VI. Correlation of helenalin and alloisotenulin. Journal of the American Chemical Society, 1958, vol. 80, no. 18, p. 4876-4879.
Herz, Werner., Jayaraman, P., Watanabe, Hiroshi. Constituents of Helenium species. IX. Sesquiterpene lactones of H. flexuosum Raf. and H. campestre Small.. Journal of the American Chemical Society, 1960, vol. 82, p. 2276-8. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature